Unknown

Dataset Information

0

Association between Proinflammatory Markers, Leukocyte-Endothelium Interactions, and Carotid Intima-Media Thickness in Type 2 Diabetes: Role of Glycemic Control.


ABSTRACT: Glycated hemoglobin monitorization could be a tool for maintaining type 2 diabetes (T2D) under control and delaying the appearance of cardiovascular events. This cross-sectional study was designed to assess the role of glycemic control in modulating early-stage markers of cardiovascular complications. One hundred and eight healthy controls and 161 type 2 diabetic patients were recruited and distributed according to their glycemic control, setting the threshold at 6.5% (good control). Biochemical and anthropometrical parameters were registered during the initial visit, and peripheral blood was extracted to obtain polymorphonuclear cells and analyze inflammatory markers, adhesion molecules, leukocyte-endothelium interactions, and carotid intima-media thickness. Correlations between these parameters were explored. We found that inflammatory markers and adhesion molecules were augmented in type 2 diabetic subjects with poor glycemic control. Polymorphonuclear leukocytes interacted more with the endothelium in the diabetic population, and even more significantly in the poorly controlled subjects. In parallel, carotid intima-media thickness was also increased in the diabetic population, and the difference was greater among poorly controlled subjects. Finally, correlation measurement revealed that carotid intima-media thickness was related to glycemic control and lipid metabolism in diabetic patients. Our results suggest that glycemic control delays the onset of cardiovascular comorbidities in diabetic subjects.

SUBMITTER: de Maranon AM 

PROVIDER: S-EPMC7465892 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Association between Proinflammatory Markers, Leukocyte-Endothelium Interactions, and Carotid Intima-Media Thickness in Type 2 Diabetes: Role of Glycemic Control.

de Marañón Aranzazu Martinez AM   Iannantuoni Francesca F   Abad-Jiménez Zaida Z   Canet Francisco F   Díaz-Pozo Pedro P   López-Domènech Sandra S   Roldán-Torres Ildefonso I   Morillas Carlos C   Rocha Milagros M   Víctor Víctor M VM  

Journal of clinical medicine 20200805 8


Glycated hemoglobin monitorization could be a tool for maintaining type 2 diabetes (T2D) under control and delaying the appearance of cardiovascular events. This cross-sectional study was designed to assess the role of glycemic control in modulating early-stage markers of cardiovascular complications. One hundred and eight healthy controls and 161 type 2 diabetic patients were recruited and distributed according to their glycemic control, setting the threshold at 6.5% (good control). Biochemical  ...[more]

Similar Datasets

| S-EPMC5084362 | biostudies-literature
| S-EPMC3153949 | biostudies-literature
| S-EPMC5063685 | biostudies-literature
| S-EPMC10963553 | biostudies-literature
| S-EPMC6518654 | biostudies-literature
| S-EPMC5850165 | biostudies-literature
| S-EPMC4008829 | biostudies-literature
| S-EPMC3116932 | biostudies-literature
| S-EPMC11350994 | biostudies-literature
| S-EPMC2717175 | biostudies-literature